Tools
Tools
Behzadifar, Meysam, Shahabi, Saeed, Bakhtiari, Ahad, Azari, Samad, Yarahmadi, Mohammad, Aryankhesal, Aidin 
ORCID: https://orcid.org/0000-0002-6695-227X, Teli, Banafsheh Darvishi and Behzadifar, Masoud
(2026)
Challenges of implementing health technology assessment in the Iranian pharmaceutical industry.
Eastern Mediterranean Health Journal, 32 (8).
pp. 521-527.
ISSN 1020-3397
Preview |
PDF (1020-3397-2026-3208-521-527-eng)
- Published Version
Available under License Creative Commons Attribution Non-commercial Share Alike. Download (112kB) | Preview |
Abstract
Background: Health technology assessment remains underdeveloped in the Islamic Republic of Iran, with limited systematic application in the pharmaceutical sector. Aim: To identify the challenges facing the development and implementation of health technology assessment in the Iranian pharmaceutical industry. Methods: Between August and November 2024 we conducted in-depth interviews with 15 experts who have experience in implementing health technology assessment, on the development and implementation of health technology assessment in the pharmaceutical sector of Islamic Republic Iran. We used MAXQDA version 12 for data management and analysed the data using the Braun and Clarke’s 6-step thematic analysis. Results: The major challenges identified were the absence of centralised health technology assessment governance for pharmaceuticals, insufficient and unstable funding, resistance to change, limited awareness about health technology assessment, limited health technology assessment capacity, absence of a legal enforcement framework, political interference, and the strong influence of pharmaceutical companies. Participants noted the availability of international partnerships on health technology assessment. Conclusion: Several complex and multilevel barriers hinder the development and implementation of health technology assessment in the Iranian pharmaceutical industry. There is a need for actions to strengthen health technology assessment in the country to support evidence-based policymaking, resource optimisation and equitable access to essential medicines.
| Item Type: | Article |
|---|---|
| Additional Information: | Publisher Copyright: © Authors 2026; Licensee: World Health Organization. |
| Uncontrolled Keywords: | health policy,health technology assessment,islamic republic of iran,pharmaceutical industry,general medicine ,/dk/atira/pure/subjectarea/asjc/2700/2700 |
| Faculty \ School: | Faculty of Medicine and Health Sciences > School of Health Sciences |
| Related URLs: | |
| Depositing User: | LivePure Connector |
| Date Deposited: | 08 Oct 2026 15:08 |
| Last Modified: | 08 Oct 2026 15:08 |
| URI: | https://ueaeprints.uea.ac.uk/id/eprint/104759 |
| DOI: | 10.26719/2026.32.8.521 |
Downloads
Downloads per month over past year
Actions (login required)
 |
View Item |